Suppr超能文献

优化胶质母细胞瘤老年患者的管理:基于卑诗省癌症登记处真实世界数据的生存预测在线工具。

Optimizing management of the elderly patient with glioblastoma: Survival prediction online tool based on BC Cancer Registry real-world data.

作者信息

Zhao Rachel, Zeng Jonathan, DeVries Kimberly, Proulx Ryan, Krauze Andra Valentina

机构信息

University of British Columbia, Faculty of Medicine, Vancouver, British Columbia, Canada.

Cancer Surveillance & Outcomes, BC Cancer, Vancouver, British Columbia, Canada.

出版信息

Neurooncol Adv. 2022 Apr 13;4(1):vdac052. doi: 10.1093/noajnl/vdac052. eCollection 2022 Jan-Dec.

Abstract

BACKGROUND

Glioblastoma (GBM) is associated with fatal outcomes and devastating neurological presentations especially impacting the elderly. Management remains controversial and representation in clinical trials poor. We generated 2 nomograms and a clinical decision making web tool using real-world data.

METHODS

Patients ≥60 years of age with histologically confirmed GBM (ICD-O-3 histology codes 9440/3, 9441/3, and 9442/3) diagnosed 2005-2015 were identified from the BC Cancer Registry ( = 822). Seven hundred and twenty-nine patients for which performance status was captured were included in the analysis. Age, performance and resection status, administration of radiation therapy (RT), and chemotherapy were reviewed. Nomograms predicting 6- and 12-month overall survival (OS) probability were developed using Cox proportional hazards regression internally validated by -index. A web tool powered by JavaScript was developed to calculate the survival probability.

RESULTS

Median OS was 6.6 months (95% confidence interval [CI] 6-7.2 months). Management involved concurrent chemoradiation (34%), RT alone (42%), and chemo alone (2.3%). Twenty-one percent of patients did not receive treatment beyond surgical intervention. Age, performance status, extent of resection, chemotherapy, and RT administration were all significant independent predictors of OS. Patients <80 years old who received RT had a significant survival advantage, regardless of extent of resection (hazard ratio range from 0.22 to 0.60, CI 0.15-0.95). A nomogram was constructed from all 729 patients (Harrell's Concordance Index = 0.78 [CI 0.71-0.84]) with a second nomogram based on subgroup analysis of the 452 patients who underwent RT (Harrell's Concordance Index = 0.81 [CI 0.70-0.90]). An online calculator based on both nomograms was generated for clinical use.

CONCLUSIONS

Two nomograms and accompanying web tool incorporating commonly captured clinical features were generated based on real-world data to optimize decision making in the clinic.

摘要

背景

胶质母细胞瘤(GBM)与致命结局和严重的神经功能表现相关,对老年人影响尤甚。其治疗仍存在争议,且在临床试验中的代表性较差。我们利用真实世界数据生成了两个列线图和一个临床决策网络工具。

方法

从卑诗省癌症登记处识别出2005年至2015年期间诊断为组织学确诊GBM(ICD - O - 3组织学编码9440/3、9441/3和9442/3)且年龄≥60岁的患者(n = 822)。分析纳入了729例记录了体能状态的患者。回顾了年龄、体能和切除状态、放射治疗(RT)及化疗的使用情况。使用Cox比例风险回归法构建预测6个月和12个月总生存(OS)概率的列线图,并通过一致性指数进行内部验证。开发了一个由JavaScript驱动的网络工具来计算生存概率。

结果

中位OS为6.6个月(95%置信区间[CI] 6 - 7.2个月)。治疗方式包括同步放化疗(34%)、单纯RT(42%)和单纯化疗(2.3%)。21%的患者在手术干预后未接受其他治疗。年龄、体能状态、切除范围、化疗及RT使用均为OS的显著独立预测因素。年龄<80岁且接受RT的患者具有显著的生存优势,无论切除范围如何(风险比范围为0.22至0.60,CI 0.15 - 0.95)。根据所有729例患者构建了一个列线图(Harrell一致性指数 = 0.78 [CI 0.71 - 0.84]),并基于对452例接受RT患者的亚组分析构建了第二个列线图(Harrell一致性指数 = 0.81 [CI 0.70 - 0.90])。生成了一个基于两个列线图的在线计算器供临床使用。

结论

基于真实世界数据生成了两个列线图及配套网络工具,纳入了常见的临床特征,以优化临床决策。

相似文献

引用本文的文献

本文引用的文献

3
Predictors of survival in elderly patients undergoing surgery for glioblastoma.胶质母细胞瘤老年手术患者生存的预测因素。
Neurooncol Adv. 2021 Jun 21;3(1):vdab083. doi: 10.1093/noajnl/vdab083. eCollection 2021 Jan-Dec.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验